ICU Medical, Incorporated (NASDAQ:ICUI) Expected to Announce Earnings of $1.62 Per Share

Share on StockTwits

Brokerages predict that ICU Medical, Incorporated (NASDAQ:ICUI) will announce $1.62 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for ICU Medical’s earnings. The lowest EPS estimate is $1.57 and the highest is $1.66. ICU Medical reported earnings per share of $2.07 in the same quarter last year, which would indicate a negative year over year growth rate of 21.7%. The company is scheduled to announce its next earnings report on Thursday, February 27th.

On average, analysts expect that ICU Medical will report full year earnings of $7.85 per share for the current year, with EPS estimates ranging from $7.80 to $7.89. For the next fiscal year, analysts forecast that the business will post earnings of $6.88 per share, with EPS estimates ranging from $6.65 to $7.10. Zacks’ earnings per share averages are a mean average based on a survey of research firms that that provide coverage for ICU Medical.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Monday, November 11th. The medical instruments supplier reported $1.65 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.62 by $0.03. The business had revenue of $307.47 million during the quarter, compared to the consensus estimate of $297.83 million. ICU Medical had a net margin of 5.66% and a return on equity of 12.13%. The business’s revenue for the quarter was down 6.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.85 earnings per share.

A number of analysts have commented on the company. TheStreet cut ICU Medical from a “b-” rating to a “c+” rating in a research report on Monday, August 12th. Raymond James increased their price objective on ICU Medical from $185.00 to $203.00 and gave the company a “positive” rating in a report on Tuesday, November 12th. ValuEngine upgraded ICU Medical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Zacks Investment Research cut ICU Medical from a “hold” rating to a “sell” rating in a research note on Wednesday, August 14th. Finally, BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a report on Thursday, November 21st. One analyst has rated the stock with a sell rating and three have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $242.00.

In other news, Director Robert S. Swinney sold 373 shares of the stock in a transaction on Monday, October 14th. The shares were sold at an average price of $153.49, for a total value of $57,251.77. Following the sale, the director now owns 18,845 shares in the company, valued at $2,892,519.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director George A. Lopez sold 20,000 shares of the stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $184.29, for a total transaction of $3,685,800.00. Following the completion of the sale, the director now owns 368,864 shares in the company, valued at approximately $67,977,946.56. The disclosure for this sale can be found here. Insiders own 11.40% of the company’s stock.

A number of large investors have recently bought and sold shares of ICUI. Advisory Services Network LLC raised its stake in shares of ICU Medical by 70.2% during the 2nd quarter. Advisory Services Network LLC now owns 143 shares of the medical instruments supplier’s stock valued at $36,000 after buying an additional 59 shares during the last quarter. Quadrant Capital Group LLC boosted its stake in shares of ICU Medical by 1,389.5% in the third quarter. Quadrant Capital Group LLC now owns 283 shares of the medical instruments supplier’s stock worth $43,000 after buying an additional 264 shares during the last quarter. Quest Capital Management Inc. ADV acquired a new stake in ICU Medical during the third quarter worth about $80,000. Huntington National Bank grew its holdings in ICU Medical by 17.9% during the third quarter. Huntington National Bank now owns 559 shares of the medical instruments supplier’s stock worth $89,000 after acquiring an additional 85 shares during the period. Finally, DRW Securities LLC purchased a new position in ICU Medical during the second quarter valued at approximately $204,000. 91.85% of the stock is currently owned by institutional investors.

Shares of ICUI stock opened at $185.24 on Thursday. The firm has a market capitalization of $3.83 billion, a price-to-earnings ratio of 24.03 and a beta of 0.92. The business has a fifty day moving average of $172.59 and a 200 day moving average of $196.36. ICU Medical has a 1 year low of $148.89 and a 1 year high of $259.72.

About ICU Medical

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Read More: Understanding Compound Annual Growth Rate (CAGR)

Get a free copy of the Zacks research report on ICU Medical (ICUI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.